Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Agilent Technologies	Mettler-Toledo International	Illumina	10x Genomics	Bio-Rad Laboratories
Symbol	NYSE:A	NYSE:MTD	NASDAQ:ILMN	NASDAQ:TXG	NYSE:BIO
Price Information
Current Price	$133.90	$1,278.56	$383.94	$146.36	$608.01
52 Week Range	Buy	Hold	Hold	Buy	Buy
MarketRank™
Overall Score	1.8	1.3	1.6	1.8	1.5
Analysis Score	2.4	0.9	2.1	3.4	2.5
Community Score	3.0	2.1	2.6	3.2	2.4
Dividend Score	1.7	0.0	0.0	0.0	0.0
Ownership Score	0.0	1.7	1.7	1.7	0.8
Earnings & Valuation Score	1.9	1.9	1.9	0.6	1.9
Analyst Ratings
Consensus Recommendation	Buy	Hold	Hold	Buy	Buy
Consensus Price Target	$107.44	$971.38	$374.50	$181.44	$700.00
% Upside from Price Target	-19.76% downside	-24.03% downside	-2.46% downside	23.97% upside	15.13% upside
Trade Information
Market Cap	$40.80 billion	$29.82 billion	$56.06 billion	$15.92 billion	$18.15 billion
Beta	1.04	1.04	1.14	1.39	0.83
Average Volume	1,671,539	117,335	1,129,601	772,422	199,021
Sales & Book Value
Annual Revenue	$5.34 billion	$3.01 billion	$3.54 billion	$245.89 million	$2.31 billion
Price / Sales	7.64	9.91	15.82	64.73	7.85
Cashflow	$4.58 per share	$28.36 per share	$8.73 per share	N/A	$7.20 per share
Price / Cash	29.24	45.08	43.98	N/A	84.42
Book Value	$15.81 per share	$17.28 per share	$31.38 per share	$4.36 per share	$192.32 per share
Price / Book	8.47	73.99	12.24	33.57	3.16
Profitability
Net Income	$719 million	$561.11 million	$1.00 billion	$-31,250,000.00	$1.76 billion
EPS	$3.28	$22.77	$6.57	($0.80)	$7.06
Trailing P/E Ratio	58.22	53.79	89.08	N/A	5.20
Forward P/E Ratio	32.27	45.50	73.41	N/A	59.61
P/E Growth	3.82	3.58	9.83	N/A	N/A
Net Margins	13.47%	19.36%	19.70%	-51.27%	147.91%
Return on Equity (ROE)	21.02%	144.89%	15.93%	-19.98%	3.77%
Return on Assets (ROA)	10.73%	21.11%	10.09%	-14.38%	2.74%
Dividend
Annual Payout	$0.78	N/A	N/A	N/A	N/A
Dividend Yield	0.58%	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	-0.92%	N/A	N/A	N/A	N/A
Payout Ratio	23.78%	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	1 Years	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.47%	2.64%	0.14%	N/A	N/A
Current Ratio	2.33%	1.37%	3.88%	6.19%	2.36%
Quick Ratio	1.84%	0.99%	3.51%	6.01%	1.71%
Ownership Information
Institutional Ownership Percentage	N/A	93.18%	89.97%	68.84%	63.03%
Insider Ownership Percentage	N/A	3.20%	0.38%	13.28%	27.50%
Miscellaneous
Employees	16,400	14,900	7,800	852	8,000
Shares Outstanding	304.70 million	23.32 million	146.00 million	108.75 million	29.84 million
Next Earnings Date	5/25/2021 (Confirmed)	7/29/2021 (Estimated)	8/5/2021 (Estimated)	8/10/2021 (Estimated)	7/29/2021 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Source	Headline
	Covid-19 Detection Kits Market Forecast 2026 \| BGI, Abbott Laboratories, F. Hoffmann-La Roche, Guangzhou Wondfo Biotech, Qiagen, Seegene openpr.com - May 6 at 11:45 PM
	Bio-Rad Laboratories (NYSE:BIO) Issues FY 2021 Earnings Guidance americanbankingnews.com - May 6 at 12:10 PM
	Bio-Rad launches its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe cambridgenetwork.co.uk - May 5 at 10:42 PM
	Bio-Rad Ruling Highlights IP Assignment Clause Limits law360.com - May 5 at 5:42 PM
	Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $630.13 americanbankingnews.com - May 4 at 11:06 AM
	Fed. Circ. OKs ITC Ruling That Bio-Rad Infringed 10x Patents law360.com - May 1 at 1:08 AM
	Bio-Rad Laboratories (NYSE:BIO) Issues Quarterly Earnings Results, Beats Estimates By $2.71 EPS americanbankingnews.com - April 30 at 8:18 PM
	Bio-Rad Laboratories (NYSE:BIO) Updates FY 2021 Earnings Guidance americanbankingnews.com - April 29 at 7:44 PM
	Bio-Rad: Q1 Earnings Snapshot \| Raleigh News & Observer newsobserver.com - April 29 at 6:40 PM
	What are The Major Factors Expected to Limit The Growth Of The High Throughput Screening Market? marketwatch.com - April 28 at 9:43 AM
	In Situ Hybridization (ISH) Market to Grow by USD 475.05 Million During 2021-2025\|Technavio prnewswire.com - April 27 at 11:58 PM
	What are The Major Factors Expected to Limit The Growth Of The Healthcare Life Science & Chemical Instrumentation Market? marketwatch.com - April 27 at 1:58 PM
	Research Antibodies & Reagents Market Projections and Future Opportunities Recorded for the Period until 2025\| Danaher, Bio-Rad Laboratories marketwatch.com - April 27 at 1:58 PM
	Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of COVID-19 Vaccine technologynetworks.com - April 27 at 1:58 PM
	Bio-Rad Laboratories B earnings preview: what to expect markets.businessinsider.com - April 27 at 1:58 PM
	Global Infectious Disease Diagnostics Markets Report 2020-2027 - Shift in Focus from Centralized Laboratories to POC Testing Services in.finance.yahoo.com - April 27 at 8:57 AM
	North America Hemoglobin Testing Market Analysis by Region Analysis and Business Development, By 2025 marketwatch.com - April 27 at 12:14 AM
	In Vitro Toxicology Testing Market Expected to Experience Bolstering Sales during Forecast Period, 2018 to 2026 kyn24.com - April 25 at 8:26 AM
	Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release finance.yahoo.com - April 22 at 2:33 PM
	Bio-Rad Laboratories, Inc.: Bio-Rad Benefiting From Record Flow-Through Profits From Sartorius; Diagnostic Recovery Underway finance.yahoo.com - April 22 at 9:31 AM
	Bio-Rad Laboratories (BIO) to Release Quarterly Earnings on Thursday americanbankingnews.com - April 22 at 3:16 AM
	qRT-PCR Market 2021 Top Companies report covers are Thermo Fisher Scientific (U.S.),Bio-Rad Laboratori and Market Share, Demand Forecast to 2025 marketwatch.com - April 21 at 2:03 PM
	Quality Control in CAR T-Cell Manufacturing Using ddPCR technologynetworks.com - April 20 at 9:33 AM
	Capillary Electrophoresis Equipment Market Latest Report: Top Company Profiles, CAGR, Production And Sales Estimations and Forecast 2026 marketwatch.com - April 19 at 12:29 PM
	Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021 finance.yahoo.com - April 15 at 1:26 PM

Date	Company	Brokerage	Action
5/3/2021	Agilent Technologies	Canaccord Genuity	Boost Price Target
3/24/2021	Agilent Technologies	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Upgrade
3/19/2021	Agilent Technologies	Redburn Partners	Upgrade
2/17/2021	Agilent Technologies	KeyCorp	Boost Price Target
2/17/2021	Agilent Technologies	Robert W. Baird	Boost Price Target
2/17/2021	Agilent Technologies	Wells Fargo & Company	Boost Price Target
2/17/2021	Agilent Technologies	Cowen	Boost Price Target
2/17/2021	Agilent Technologies	SVB Leerink	Boost Price Target
2/17/2021	Agilent Technologies	Bank of America	Upgrade
1/12/2021	Agilent Technologies	Mizuho	Initiated Coverage
12/23/2020	Agilent Technologies	MKM Partners	Initiated Coverage
12/3/2020	Agilent Technologies	Sanford C. Bernstein	Upgrade
12/2/2020	Agilent Technologies	The Goldman Sachs Group	Initiated Coverage
11/25/2020	Agilent Technologies	UBS Group	Upgrade
11/24/2020	Agilent Technologies	JPMorgan Chase & Co.	Boost Price Target
11/17/2020	Agilent Technologies	Cleveland Research	Upgrade
12/16/2020	Mettler-Toledo International	Smith Barney Citigroup	Boost Price Target
5/8/2020	Mettler-Toledo International	Cfra	Boost Price Target
4/19/2020	Mettler-Toledo International	Evercore ISI	Downgrade
4/2/2020	Mettler-Toledo International	Stifel Nicolaus	Lower Price Target
4/2/2020	Mettler-Toledo International	Wolfe Research	Downgrade
3/26/2020	Mettler-Toledo International	Barclays	Upgrade
3/31/2021	Illumina	Atlantic Securities	Downgrade
2/16/2021	Illumina	BTIG Research	Boost Price Target
2/12/2021	Illumina	Piper Sandler	Boost Price Target
12/22/2020	Illumina	OTR Global	Upgrade
12/1/2020	Illumina	Argus	Lower Price Target
3/22/2021	10x Genomics	William Blair	Initiated Coverage
2/25/2021	10x Genomics	Morgan Stanley	Boost Price Target
2/5/2021	Bio-Rad Laboratories	Jefferies Financial Group	Boost Price Target
5/9/2019	Bio-Rad Laboratories	Deutsche Bank Aktiengesellschaft	Boost Price Target

(Data available from 5/8/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources